Sep 2026
A programmable NIR-II-activated phase-change nanoplatform for antibacterial therapy and microenvironment remodeling in diabetic chronic wounds.
This study establishes CRP as a nanoplatform that exhibits quantitatively confirmed photothermal-chemical synergistic antibacterial performance and highlights its potential for the precision treatment of refractory diabetic chronic wounds.
Kai-Wen Chang, Zhan Gao, Ke Xue et al.
· Journal of Controlled Releas... · 0 citations